VaxSyna INC.

Startup

VaxSyna is developing a patent-protect vaccine platform technology to advance solutions for the fight against diseases. Our vaccine platform is self-adjuvanting, easily tailored to a target pathogen antigen, and generates protective immune responses in 1-2 vaccine doses. Our vaccine platform can be utilized to create both prophylactic and therapeutic vaccines to maximize impact. Driven by innovation and fueled by the need for new vaccine strategies, we invite you to join us in overcoming global diseases. One vaccine platform - endless solutions for better health. 

website